UP’s 100-day intensive TB campaign identifies 9,340 cases in first month
Under the directives of Chief Minister Yogi Adityanath, a 100-day intensive tuberculosis (TB) campaign is underway across Uttar Pradesh.
Under the directives of Chief Minister Yogi Adityanath, a 100-day intensive tuberculosis (TB) campaign is underway across Uttar Pradesh.
The Uttar Pradesh government has screened more than 27 lakh citizens as part of a comprehensive campaign to eliminate tuberculosis (TB) from Uttar Pradesh by 2025.
Union Health Minister Jagat Prakash Nadda on Saturday held a meeting with Chief Ministers/LGs and state Health Ministers, requesting their support toward the ongoing 100-day intensified TB elimination campaign.
Lok Sabha Speaker Om Birla, on Sunday, urged the Members of Parliament (MPs) to make ‘TB Mukt Bharat’ and ‘Nasha Mukt Bharat’ campaigns a ‘Jan-Andolan’ and develop the spirit of healthy competition among themselves to make India free from Tuberculosis (TB) disease by 2025.
Emphasising that India's fight against tuberculosis just got stronger, Prime Minister Narendra Modi announced the starting of a special 100 day campaign today with a focus on the high burden TB districts.
In a significant acknowledgment of the country's efforts towards eradication of tuberculosis, Prime Minister Narendra Modi on Sunday highlighted the nation's achievements in reducing TB incidence.
Prime Minister Narendra Modi on Sunday lauded India's progress in the fight against Tuberculosis saying the decline in TB incidence is an outcome of the country's dedicated and innovative efforts.
The Uttar Pradesh government has achieved another milestone in the fight against TB, demonstrating significant success in identifying and treating TB patients across the state.
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
Patanjali’s research on Solanum virginianum extract (SVE) or ‘Chhoti Kateli’ aims to develop herbal therapies that can either stand alone or complement existing anti-TB drugs.
